ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism

Clinical trial NCT00135304 · COMPLETED

Trial details

NCT number: NCT00135304
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism

Start date: 2005-08-01
Primary completion: 2006-10-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.